Trial intelligence / Profile preview

Assessment of the efficacy and safety of polynucleotide injection for preventing post-surgical scars

TCTR20250122002Phase 2Enrolling by invitation

Sponsor
SW Healthcare
Start
Jun 2025
Countries
1
01

Overview

Phase 2, randomised trial in surgical scar (2 arms), sponsored by SW Healthcare. Started Jun 2025; status: enrolling by invitation.

02

Conditions

surgical scar

Beyond the preview

Go deeper on TCTR20250122002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250122002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call